Novartis registers new Phase IIIb IgAN trial and VEXAS Phase 2; gMG trial still activeSep 30Weekly roundup, 7 itemsarumakimigatrasentanUpdated
Novartis registers Phase 3 urticaria, pruritus trials; posts malaria and leishmaniasis dataSep 11Weekly roundup, 5 itemscipargaminINE963
Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruitingAug 21Weekly roundup, 8 itemsGIA632inclisiran
Novartis: TOUR006 Phase 2 results posted in CKD; eltrombopag pediatric PK study also reports outAug 12Weekly roundup, 5 itemseltrombopagNovartis
Novartis posts pelacarsen Phase 3 apheresis results, updates three drug labelsJul 17Weekly roundup, 8 itemscarbamazepineimatinib
Novartis: Mayzent label update approved; four real-world studies registered or recruitingJul 2Weekly roundup, 7 itemsalpelisibFludarabine
Sign inSign in